ITTO20020286A1 - USE OF THE PROTEIN P17 ISOLATED FOR THE PREPARATION OF A MEDICATION SUITABLE TO INHIBIT THE IMMUNOSTIMULATING EFFECTS THAT THE PROTEIN PRODUCED D - Google Patents
USE OF THE PROTEIN P17 ISOLATED FOR THE PREPARATION OF A MEDICATION SUITABLE TO INHIBIT THE IMMUNOSTIMULATING EFFECTS THAT THE PROTEIN PRODUCED DInfo
- Publication number
- ITTO20020286A1 ITTO20020286A1 IT2002TO000286A ITTO20020286A ITTO20020286A1 IT TO20020286 A1 ITTO20020286 A1 IT TO20020286A1 IT 2002TO000286 A IT2002TO000286 A IT 2002TO000286A IT TO20020286 A ITTO20020286 A IT TO20020286A IT TO20020286 A1 ITTO20020286 A1 IT TO20020286A1
- Authority
- IT
- Italy
- Prior art keywords
- protein
- inhibit
- isolated
- preparation
- immunostimulating effects
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2002TO000286A ITTO20020286A1 (en) | 2002-03-29 | 2002-03-29 | USE OF THE PROTEIN P17 ISOLATED FOR THE PREPARATION OF A MEDICATION SUITABLE TO INHIBIT THE IMMUNOSTIMULATING EFFECTS THAT THE PROTEIN PRODUCED D |
AU2003219101A AU2003219101A1 (en) | 2002-03-29 | 2003-03-27 | Use of the p17 protein of hiv in isolated form for the preparation of a medicament for administration to hiv seropositive patients, as well as pharmaceutical compositions comprising said protein |
PCT/EP2003/003177 WO2003082908A2 (en) | 2002-03-29 | 2003-03-27 | Use of the p17 protein of hiv in isolated form for the preparation of a medicament for administration to hiv seropositive patients, as well as pharmaceutical compositions comprising said protein |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2002TO000286A ITTO20020286A1 (en) | 2002-03-29 | 2002-03-29 | USE OF THE PROTEIN P17 ISOLATED FOR THE PREPARATION OF A MEDICATION SUITABLE TO INHIBIT THE IMMUNOSTIMULATING EFFECTS THAT THE PROTEIN PRODUCED D |
Publications (2)
Publication Number | Publication Date |
---|---|
ITTO20020286A0 ITTO20020286A0 (en) | 2002-03-29 |
ITTO20020286A1 true ITTO20020286A1 (en) | 2003-09-29 |
Family
ID=27638968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT2002TO000286A ITTO20020286A1 (en) | 2002-03-29 | 2002-03-29 | USE OF THE PROTEIN P17 ISOLATED FOR THE PREPARATION OF A MEDICATION SUITABLE TO INHIBIT THE IMMUNOSTIMULATING EFFECTS THAT THE PROTEIN PRODUCED D |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003219101A1 (en) |
IT (1) | ITTO20020286A1 (en) |
WO (1) | WO2003082908A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITTO20080027A1 (en) | 2008-01-15 | 2009-07-16 | Medestea Res & Production S P A | SHAPED FORM OF HIV PROTEIN P17. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0293792A3 (en) * | 1987-06-01 | 1990-01-17 | The Du Pont Merck Pharmaceutical Company | Human immunodeficiency virus gag-encoded proteins |
DK643188A (en) * | 1987-11-24 | 1989-05-25 | Smithkline Biolog | EXPRESSION OF HIV PROTEINS IN E.COLI AND S.CEREVISIAE |
GB9703802D0 (en) * | 1997-02-24 | 1997-04-16 | Kingsman Susan M | Anti-hiv peptides and proteins |
EP1417222B1 (en) * | 2001-08-07 | 2010-08-18 | Medestea Internazionale S.p.A. | Isolated polypeptides based on the neutralizing epitope of the p17 protein of hiv useful as vaccines, and neutralizing anti-p17 antibodies which specifically recognize said neutralizing epitope |
-
2002
- 2002-03-29 IT IT2002TO000286A patent/ITTO20020286A1/en unknown
-
2003
- 2003-03-27 AU AU2003219101A patent/AU2003219101A1/en not_active Abandoned
- 2003-03-27 WO PCT/EP2003/003177 patent/WO2003082908A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2003219101A8 (en) | 2003-10-13 |
AU2003219101A1 (en) | 2003-10-13 |
ITTO20020286A0 (en) | 2002-03-29 |
WO2003082908A2 (en) | 2003-10-09 |
WO2003082908A3 (en) | 2004-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR106702A2 (en) | USE OF ANTI-NGF ANTAGONIST ANTIBODY FOR THE PREPARATION OF A MEDICINAL PRODUCT | |
DK1567112T3 (en) | Thiazolidine-4-ones to inhibit hYAK3 proteins | |
NO20033973L (en) | Seismic mapping to the sea | |
ATE517855T1 (en) | ANTIBODIES TO CHEMOTACTIC MONOCYTE PROTEINS | |
NO20041018L (en) | Antibodies to OPGL | |
AU2003286922A8 (en) | Analysis of geometric surfaces by conformal structure | |
ATE380544T1 (en) | COATED SOLID PHARMACEUTICAL FORM | |
DE60213607D1 (en) | EASY TO FEED DONATE | |
IS8376A (en) | Seed protein production | |
ATE367152T1 (en) | PRODUCTION METHOD FOR LOW DOSE PHARMACEUTICAL COMPOSITION | |
NO20054662D0 (en) | Pharmaceutical composition comprising 5-methyl-2-2 '- (chloro-6'-fluoroaniline) phenylacetic acid | |
DE60220625D1 (en) | Improvements to turbomachinery injectors | |
DK1456160T3 (en) | Vitamin D analogs | |
EE200400045A (en) | Technical synthesis method for the preparation of tropenol | |
ITTO20020286A1 (en) | USE OF THE PROTEIN P17 ISOLATED FOR THE PREPARATION OF A MEDICATION SUITABLE TO INHIBIT THE IMMUNOSTIMULATING EFFECTS THAT THE PROTEIN PRODUCED D | |
ATE546141T1 (en) | PHARMACEUTICAL INJECTION PREPARATION | |
ITMI20032141A1 (en) | PROCEDURE TO INFLUENCE THE MASS CONSTANCE OF | |
ITRM20030196A1 (en) | USE OF REAGENTS FOR THE PREPARATION OF A DRUG | |
ITMI20031994A1 (en) | PROCEDURE FOR THE PREPARATION OF FLUDARABINA FOSFATO | |
FI20010808A0 (en) | Procedure for pointing to a point in a measurement space | |
IS8103A (en) | Pharmaceutical preparation containing macrolide immune response | |
ITBO20020356A0 (en) | MODULAR SECTIONAL STRUCTURE FOR FURNISHING | |
ITTN20020004U1 (en) | SELF-LEVELING SCALE USEFUL TO OVERCOME VARIABLE DIFFERENCES | |
NO20010865D0 (en) | Global seismic connections | |
ITBZ20030031A1 (en) | PROCEDURE FOR THE PREPARATION OF A SUBSTRATE |